Antibodies News and Research

RSS

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Researchers investigated the immunological mechanisms behind the decreasing efficacy of COVID-19 vaccines by evaluating the durability and magnitude of neutralizing antibodies and memory B and T cell responses to booster doses of mRNA COVID-19 vaccine.

8 Dec 2022

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant.

7 Dec 2022

Vaccination against E. coli could help prevent some forms of childhood malnutrition, stunting

Diarrhea is no longer the killer it was in the mid-20th century, when an estimated 4.5 million children under age 5 died of it every year.

7 Dec 2022

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Dr Arturo Reyes Sandoval is the Director of the National Polytechnic Institute, one of the largest and most prestigious universities in Mexico.

7 Dec 2022

Researchers detect the Alongshan virus for the first time in Swiss ticks

The Alongshan virus was discovered in China only five years ago. Now researchers at the University of Zurich have found the novel virus for the first time in Swiss ticks.

7 Dec 2022

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

In a recent Morbidity and Mortality Weekly Report (MMWR), the United States Center for Disease Control and Prevention (U.S.-CDC) published the preliminary results of the National Health and Nutrition Examination Survey (NHANES) for August 2021–May 2022.

7 Dec 2022

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

Researchers attempted to establish an association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load, indicating its ribonucleic acid (RNA) levels, and the presence of infectious virions.

7 Dec 2022

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Researchers evaluated the immunogenicity, boosting efficacy, and safety of single-dose and two-dose MVA-BN (modified vaccinia Ankara-Bavarian Nordic) vaccinations in comparison to replicating smallpox vaccines.

7 Dec 2022

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

Nearly three years into the pandemic, many of us now carry antibodies against the virus-;due to an infection or two, a few doses of mRNA vaccine, or a round of monoclonal-antibody treatment.

6 Dec 2022

Colorectal cancer doesn’t wait - DNA methylation tests facilitate earlier treatment

In this interview, Yantao Li and Zhe Wang, Director of Cancer Early Screening Products and the Product Director of Oncology at BGI Genomics, talks to NewsMedical about colorectal cancer (CRC), including why incidences are important and the importance of screening.

From BGI Genomics 6 Dec 2022

The critical role of flow cytometry in CAR+ T-Cell trials

In this interview, Ryan Muise talks to AZoNetwork about the added value of using flow cytometry in CAR T-Cell clinical trials.

From Cerba Research 6 Dec 2022

Immunopeptidome characters of human CoV-OC43-infected cells

Researchers explored T-cell epitopes derived from human seasonal coronavirus OC43.

5 Dec 2022

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Researchers developed an mRNA technology-based vaccine candidate against the monkeypox virus and evaluated its immunogenicity in animal models.

5 Dec 2022

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Researchers from the United States developed an affordable, non-invasive, inhalable prophylactic treatment consisting of immunoglobulin (Ig) A fused nanobodies against the SARS-CoV-2 Omicron variant.

2 Dec 2022

Sharp increase in B cell population can prevent intestinal healing

B cells are critical to the proper functioning of the immune system. However, researchers at Karolinska Institutet have shown that they can sometimes do more harm than good, as their numbers greatly increase after bowel damage, preventing the tissue from healing.

2 Dec 2022

Vaccination against pertussis in pregnancy and outstanding scientific questions

A recent paper published in Vaccines summarized the data presented and the discussions in the meeting regarding pertussis vaccination in pregnancy (ViP).

2 Dec 2022

The prevalence and risk factors of pediatric post-COVID in a population-based sample

Researchers compared seropositive and seronegative children between the ages of six months and 17 years to assess the risk factors and prevalence of persistent symptoms of post-COVID syndrome.

2 Dec 2022

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

Researchers investigated passive immunization of the fetus and neonates by evaluating the antibody responses elicited by primary and booster doses of maternal SARS-CoV-2 vaccination.

2 Dec 2022

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

A Phase 1 clinical trial provides promising results for a broadly neutralizing antibody (bnAb) HIV vaccine, according to a new study.

1 Dec 2022

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

Previous infection with SARS-CoV-2 and booster vaccination protect against ICU admission and mortality following infection with the Omicron variant.

1 Dec 2022

Antibodies News and Research

Booster COVID-19 mRNA vaccinations marginally increase the durability of neutralizing antibody responses

Scientists develop new receptor “decoy” drug that potently neutralizes SARS-CoV-2 variants

Vaccination against E. coli could help prevent some forms of childhood malnutrition, stunting

UK's Newton Fund supported Mexican scientist to develop vaccines against Chikungunya, Zika and Dengue

Researchers detect the Alongshan virus for the first time in Swiss ticks

What was the SARS-CoV-2 seroprevalence among US adults during 2021 and 2022?

Researchers explore the correlation between the dynamic shedding pattern of SARS-CoV-2 and viral load

Exploring immunogenicity, boosting efficacy and safety of modified vaccinia Ankara-Bavarian Nordic vaccine

Pre-existing SARS-CoV-2 antibodies may increase the breadth of mRNA vaccines, study suggests

Colorectal cancer doesn’t wait - DNA methylation tests facilitate earlier treatment

The critical role of flow cytometry in CAR+ T-Cell trials

Immunopeptidome characters of human CoV-OC43-infected cells

Researchers develop a polyvalent lipid nanoparticle mRNA vaccine against Monkeypox virus

Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants

Sharp increase in B cell population can prevent intestinal healing

Vaccination against pertussis in pregnancy and outstanding scientific questions

The prevalence and risk factors of pediatric post-COVID in a population-based sample

Antibody responses engendered by maternal SARS-CoV-2 vaccination following initial and booster doses in maternal circulation and breastmilk

First-in-humans test provides promising results for a broadly neutralizing antibody HIV vaccine

Prior infection and vaccination protects against severe outcomes from SARS-CoV-2 Omicron infection

A new way of characterising biomolecules eBook

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Automating research - solutions and best practices

Latest Life Science News